3A Laboratories is a Biotechnology company active in Ion Channel discovery focused in three main areas: Oncology, Chronic Neuropathic Pain and Cardiovascular diseases.

3A Labs create proprietary discovery platforms to create novel assets which depending on their characteristics progress in later stages of development to novel lead stage.

Capabilities are such to progress lead assets to further stages of pre-clinical development up to Pre-clinical Proof of Concept (PC-PoC) using a wide array of cellular and animal assays.

3A Labs business model is to either license out assets which successfully passed the PC-PoC or partner with clinical stage Biotechnology and Pharmaceutical companies for clinical efficacy testing.

The company has state of the art instrumentation along with dedicated and hardworking scientists.